TCL Archive Conversation with The Cancer Letter: Is Republican Control Better Than Two-Party Stalemate? By Cancer History Project December 19, 2014
TCL Archive ACS President & COO Resigns Unexpectedly; Was Seen as Contender for CEO Position By Cancer History Project December 19, 2014
TCL Archive ODAC To Advise FDA on First Biosimilars Application Jan. 7 By Cancer History Project December 19, 2014
TCL Archive Editorial: A Record-Breaking Year for The Cancer Letter By Cancer History Project December 19, 2014
TCL Archive Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC By Cancer History Project December 19, 2014
TCL Archive In Brief: Fabien Calvo named chief scientific officer of Cancer Core Europe By Cancer History Project December 19, 2014
TCL Archive Is Everyone in Academic Medicine Unhappy? Or is it Just MD Anderson? By Cancer History Project December 12, 2014
People Larry Einhorn, pioneer of platinum-based chemotherapy, discusses 50 years of cancer treatment innovation By Cancer History Project
